Subchapter 11A - COMPOUNDING NON-STERILE PREPARATIONS IN RETAIL AND INSTITUTIONAL PHARMACIES
- § 13:39-11A.1 - Purpose and scope
- § 13:39-11A.2 - Definitions
- § 13:39-11A.3 - Prohibited compounding
- § 13:39-11A.4 - Compounding commercially available products
- § 13:39-11A.5 - Batch preparation
- § 13:39-11A.6 - Compounded non-sterile preparations for prescriber practice use
- § 13:39-11A.7 - Preparation of pharmacy generated products (PGPs) for over-the-counter sale
- § 13:39-11A.8 - Compounding area
- § 13:39-11A.9 - Equipment and supplies
- § 13:39-11A.10 - Responsibilities of the compounding pharmacist; reporting requirement
- § 13:39-11A.11 - Beyond-use dates
- § 13:39-11A.12 - Ingredient selection
- § 13:39-11A.13 - Information required to appear on prescription label
- § 13:39-11A.14 - Pharmacy technicians, pharmacy interns, and pharmacy externs; required supervision
- § 13:39-11A.15 - Audit trail; compounding record documentation
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.